Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study

Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study

Parkinson’s disease (PD) is associated with dysfunction of monoamine neurotransmitter systems. We investigated changes in the levels of monoamine and their metabolites in PD patients, together with their association to clinical profiles. PD patients and age-matched control subjects (n = 40 per group...

Full description

Bibliographic Details
Main Authors:	Patsorn Wichit, Sekh Thanprasertsuk, Onanong Phokaewvarangkul, Roongroj Bhidayasiri, Saknan Bongsebandhu-phubhakdi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Neuroscience
Subjects:	Parkinson’s disease monoamine dopamine norepinephrine epinephrine serotonin
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2021.605887/full

Similar Items

Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand
by: Sekh Thanprasertsuk, et al.
Published: (2023-01-01)

Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
by: Sekh Thanprasertsuk, et al.
Published: (2023-01-01)

How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
by: Onanong Phokaewvarangkul, et al.
Published: (2019-07-01)

Using Machine Learning for Predicting the Best Outcomes With Electrical Muscle Stimulation for Tremors in Parkinson’s Disease
by: Onanong Phokaewvarangkul, et al.
Published: (2021-09-01)

Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?
by: Sasivimol Virameteekul, et al.
Published: (2021-01-01)

Integrating technology into a successful apomorphine delivery program in Thailand: a 10-year journey of achievements with a five-motto concept
by: Onanong Phokaewvarangkul, et al.
Published: (2024-04-01)

Validity of Urinary Monoamine Assay Sales Under the “Spot Baseline Urinary Neurotransmitter Testing Marketing Model” [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Comparing the efficacy of therapeutic Thai acupressure on plantar acupoints and laser cane therapy on freezing of gait in Parkinson’s disease: a randomized non-inferiority trial
by: Yuka Miyahara, et al.
Published: (2024-01-01)

Addressing knowledge gaps in Parkinson’s disease: a report on the Movement Disorder Society’s Centre-to-Centre initiative to improve Parkinson’s disease services in Lao People’s Democratic Republic
by: Onanong Phokaewvarangkul, et al.
Published: (2020-07-01)

Tardive dyskinesia in Asia— current clinical practice and the role of neurologists in the care pathway
by: Roongroj Bhidayasiri, et al.
Published: (2024-02-01)

Peak-Dose Ballism Associated with Declining Implantable Pulse Generator Battery Life in Deep Brain Stimulation for Parkinson’s Disease
by: Denzel Chong Jen-Rei, et al.
Published: (2021-05-01)

Technological evaluation of strategies to get out of bed by people with Parkinson's disease: Insights from multisite wearable sensors
by: Jirada Sringean, et al.
Published: (2022-08-01)

Axial Sensory Tricks in Chorea–Acanthocytosis: Insights into Phenomenology
by: Roongroj Bhidayasiri, et al.
Published: (2017-06-01)

Residual effects of combined vibratory and plantar stimulation while seated influences plantar pressure and spatiotemporal gait measures in individuals with Parkinson’s disease exhibiting freezing of gait
by: Warongporn Phuenpathom, et al.
Published: (2024-01-01)

Sustained response in early responders to safinamide in patients with Parkinson's disease and motor fluctuations: A post hoc analysis of the SETTLE study
by: Roongroj Bhidayasiri, et al.
Published: (2023-03-01)

The grand challenge at the frontiers of neurotechnology and its emerging clinical applications
by: Roongroj Bhidayasiri, et al.
Published: (2024-01-01)

Correction: Impact of disease stage and age at Parkinson's onset on patients' primary concerns: Insights for targeted management.
by: Roongroj Bhidayasiri, et al.
Published: (2021-01-01)

Exploring Bedroom Usability and Accessibility in Parkinson’s Disease (PD): The Utility of a PD Home Safety Questionnaire and Implications for Adaptations
by: Roongroj Bhidayasiri, et al.
Published: (2018-05-01)

Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015-10-01)

Two-dimensional integration approach to teaching cardiovascular physiology: effectiveness and students’ perspectives
by: Kasiphak Kaikaew, et al.
Published: (2021-01-01)

Deciphering migraine pain mechanisms through electrophysiological insights of trigeminal ganglion neurons
by: S. Vongseenin, et al.
Published: (2023-09-01)

Can therapeutic Thai massage improve upper limb muscle strength in Parkinson's disease? An objective randomized-controlled trial
by: Yuka Miyahara, et al.
Published: (2018-04-01)

Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
by: Mariam B. Camacho, et al.
Published: (2017-12-01)

Pattern of cortical thinning in logopenic progressive aphasia patients in Thailand
by: Sekh Thanprasertsuk, et al.
Published: (2021-01-01)

Early Rearing Conditions Affect Monoamine Metabolite Levels During Baseline and Periods of Social Separation Stress: A Non-human Primate Model (Macaca mulatta)
by: Elizabeth K. Wood, et al.
Published: (2021-04-01)

Doctor Hope; Calming and Comforting Loneliness in Parkinson’s Disease
by: Sasivimol Virameteekul, et al.
Published: (2022-01-01)

Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches
by: Roongroj Bhidayasiri, et al.
Published: (2022-08-01)

Monoaminergic Modulation of Motor Cortex Function
by: Clément Vitrac, et al.
Published: (2017-10-01)

Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01)

Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Relative Nutritional Deficiencies Associated with Centrally Acting Monoamines [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions
by: Malik Alwindi, et al.
Published: (2023-11-01)

Beyond the Classic Segawa Disease, -Associated Neurodegenerative Parkinsonism: Practical Considerations for Physicians
by: Jirat Chenbhanich, et al.
Published: (2017-05-01)

Student academic performance in non-lecture physiology topics following the abrupt change from traditional on-site teaching to online teaching during COVID-19 pandemic
by: Pachara Varachotisate, et al.
Published: (2023-12-01)

Zanthoxylum alatum abrogates lipopolysaccharide-induced depression-like behaviours in mice by modulating neuroinflammation and monoamine neurotransmitters in the hippocampus
by: Chandana Choudhury Barua, et al.
Published: (2018-01-01)

The Discrediting of the Monoamine Hypothesis [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Urinary Neurotransmitter Testing: Considerations of Spot Baseline Norepinephrine and Epinephrine [Retraction]
by: Hinz M, et al.
Published: (2020-12-01)

Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish
by: Diego Baronio, et al.
Published: (2022-03-01)

Umami and Other Taste Perceptions in Patients With Parkinson’s Disease
by: Priya Jagota, et al.
Published: (2022-05-01)